These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36008243)

  • 1. Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study.
    Sastre J; Pinés PJ; Del Val F; Moreno-Fernandez J; Gonzalez López J; Quiroga I; Herranz S; López Gallardo G; Calderón D; López López J;
    Endocrinol Diabetes Nutr (Engl Ed); 2022; 69(7):483-492. PubMed ID: 36008243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic control and treatment patterns in patients with type 1 diabetes in Castilla-La Mancha: the DIAbetes tipo 1 in Castilla La Mancha study.
    Sastre J; Pinés PJ; Moreno J; Aguirre M; Blanco B; Calderón D; Herranz S; Roa C; Lopez J;
    Endocrinol Nutr; 2012 Nov; 59(9):539-46. PubMed ID: 23039989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To evaluate the use and clinical effect of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: Results of a multicentre study.
    Moreno-Fernandez J; Sastre J; Pinés P; Calderon-Vicente D; Gargallo J; Muñoz-Rodriguez JR
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Apr; 70(4):270-276. PubMed ID: 37116972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-cause mortality and risk factors in patients with type 1 diabetes in Castilla-La Mancha, Spain. DIACAM1 2010-2020 study.
    Pinés Corrales PJ; Sastre Marcos J; López Gallardo G; Moreno Fernández J; Herranz Antolín S; Quiroga López I; Del Val Zaballos F; González López J; Alfaro Martínez JJ;
    Prim Care Diabetes; 2024 Feb; 18(1):59-64. PubMed ID: 37977987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
    Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
    Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of flash glucose monitoring on quality of life and glycaemic control parameters in adults with type 1 diabetes mellitus⋆.
    Jiménez-Sahagún R; Gómez Hoyos E; Díaz Soto G; Nieto de la Marca MO; Sánchez Ibáñez M; Del Amo Simón S; Torres Torres B; López Gómez JJ; Delgado García E; Ortolá Buigues A; de Luis Román D
    Endocrinol Diabetes Nutr (Engl Ed); 2022 May; 69(5):345-353. PubMed ID: 35570137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
    Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
    Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control after years of completing a clinical trial on sensor-augmented pump therapy.
    Quirós C; Giménez M; Orois A; Conget I
    Endocrinol Nutr; 2015 Nov; 62(9):447-50. PubMed ID: 26521155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of the flash glucose monitoring system in type 1 diabetics: An mHealth ally in times of COVID-19.
    Cervantes-Torres L; Romero-Blanco C
    J Clin Nurs; 2023 Jul; 32(13-14):3840-3851. PubMed ID: 36071646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring.
    Díaz-Soto G; Bahíllo-Curieses MP; Jimenez R; Nieto MO; Gomez E; Torres B; López Gomez JJ; de Luis D
    Endocrinol Diabetes Nutr (Engl Ed); 2021; 68(7):465-471. PubMed ID: 34863411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study.
    Gómez-Peralta F; Menéndez E; Conde S; Conget I; Novials A;
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Nov; 68(9):642-653. PubMed ID: 34906345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
    Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
    BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [La educación multimedia como apoyo en el manejo de pacientes con diabetes tipo 2. Estudio cuasi experimental].
    Aguila IP; Velázquez-López L; Goycochea-Robles MAV; Angulo-Angulo F; Peña JE
    Cir Cir; 2018; 86(5):404-411. PubMed ID: 30226499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I; Álvarez P; García N; Roura G; Conget I;
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-monitoring of blood glucose measurements and glycaemic control in a managed care paediatric type 1 diabetes practice.
    Davey B; Segal DG
    S Afr Med J; 2015 Apr; 105(5):405-7. PubMed ID: 26242666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic control of insulin-dependent diabetes mellitus in Sudan: influence of insulin shortage.
    Elbagir MN; Eltom MA; Rosling H; Berne C
    Diabetes Res Clin Pract; 1995 Oct; 30(1):43-52. PubMed ID: 8745205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Clinical status and mortality in older adults with type 1 diabetes: Results from a public health system".
    Moreno-Fernandez J; Sastre J; Pinés P; Del Val F; Calderon-Vicente D; Quiroga I; Herranz S; Lopez Gallardo G; Gonzalez J; Muñoz-Rodriguez JR
    Diabetes Res Clin Pract; 2022 Mar; 185():109221. PubMed ID: 35101455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.